Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation Source: Eur Respir J 2009; 33: 1195-1205 Year: 2009
Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities Source: Eur Respir J 2007; 29: 156-178 Year: 2007
Prognosis: what is the contribution of inflammation to the decline in lung function in airway disease? Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease Year: 2007
Obstructive sleep apnea syndrome is an independent risk factor for progression of chronic kidney disease: A new link? Source: Annual Congress 2010 - Nocturnal cardiology: chronic heart failure, acute chest syndrome, coronary artery disease and collagen vascular disease Year: 2010
Disturbed sleep and breathing disturbances in COPD and restrictive lung diseases: evidence gaps and challenges in diagnosis and treatment Source: 5th Sleep and Breathing Conference Year: 2019
Is obstructive sleep apnoea a comorbidity of COPD and is it involved in chronic systemic inflammatory syndrome? Source: Eur Respir J 2008; 31: 1381-1382 Year: 2008
What is significant sleep disordered breathing in patients with interstitial lung disease? Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013
Evaluation of sleep related breathing disorders and obstructive sleep apnea in patients with interstitial lung disease Source: Annual Congress 2013 –Sleep disordered breathing in special situations II Year: 2013
Current perspectives in epithelial cell injury and repair: consequences for epithelial functions Source: Eur Respir Rev 2005; 14: 126-130 Year: 2005
Sleep apnoea, hypertension and vascular disease: where are we now? Source: Eur Respir Rev 2007; 16: 169-182 Year: 2007
The role of inflammatory biomarkers in obstructive sleep apnea syndrome Source: International Congress 2018 – Sleep-disordered breathing: biomarkers and genetics and the role of hypoxia, insomnia, movement disorders and sleep quality Year: 2018
Metabolic syndrome, systemic inflammation and oxidative stress in patients with severe obstructive sleep apnea: effects of CPAP Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea Year: 2008
Association between lipid peroxidation and inflammation in obstructive sleep apnoea Source: Eur Respir J 2006; 28: 378-385 Year: 2006
5-lipoxygenase pathway: one of the mediators of early atherosclerosis in obstructive sleep apnea syndrome? Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007
Systemic inflammation: a link between chronic obstructive pulmonary disease and lung cancer? Source: Annual Congress 2009 - Biological and clinical markers in lung cancer Year: 2009
Implications for disease and therapy Source: Annual Congress 2005 - Oxidative and nitrative stress: control of cell function in COPD Year: 2005
Opioid-induced sleep apnoea: complex pathophysiology, complex therapy? Source: Sleep and Breathing Conference 2017 Year: 2017
Implication of microRNA-148b in chronic obstructive lung disease of betaENaC-overexpressing mice Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome) Year: 2013
Mechanisms and assessment of vascular damage in obstructive sleep apnoea Source: Annual Congress 2013 –Yernault Lecture “Obstructive sleep apnoea as a model of systemic disease” followed by “Vascular tree and obstructive sleep apnoea” Year: 2013